Home
About
FAQ
History (5)
Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation.
Phase 1 experience with an anti-glycotope monoclonal antibody, RAV12, in recurrent adenocarcinoma.
Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment.
Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the Cancer and Leukemia Group B.
Topoisomerase I-based nonplatinum combinations in non-small-cell lung cancer.
See All 5 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Topoisomerase I-based nonplatinum combinations in non-small-cell lung cancer.
Rocha Lima CM, Joppert MG. Topoisomerase I-based nonplatinum combinations in non-small-cell lung cancer. Oncology (Williston Park). 2002 Sep; 16(9 Suppl 9):25-31.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carcinoma, Non-Small-Cell Lung
Cisplatin
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Deoxycytidine
Humans
Lung Neoplasms
Randomized Controlled Trials as Topic
authors with profiles
Caio Max S. Rocha Lima MD, MS